Open AccessA 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
Author(s) -
Donald P. Tashkin,
Bartolomé R. Celli,
Stephen Senn,
D Burkhart,
Steven Kesten,
Shailendra Menjoge,
Marc Decramer
Publication year - 2008
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa0805800
Subject(s) - medicine , bronchodilation , copd , placebo , vital capacity , tiotropium bromide , anticholinergic , anticholinergic agents , anesthesia , bronchodilator , asthma , lung function , lung , diffusing capacity , alternative medicine , pathology
Previous studies showing that tiotropium improves multiple end points in patients with chronic obstructive pulmonary disease (COPD) led us to examine the long-term effects of tiotropium therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom